相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from anopen-label,long-termextension study
Jerry Vockley et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders
Deborah Marsden et al.
GENETICS IN MEDICINE (2021)
Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders
Khaled I. Alatibi et al.
CELLS (2021)
Development and characterization of a mouse model for Acad9 deficiency
Andrew Sinsheimer et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD)
Abbe N. Vallejo et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Impact of mRNA chemistry and manufacturing process on innate immune activation
Jennifer Nelson et al.
SCIENCE ADVANCES (2020)
Messenger RNA therapy for rare genetic metabolic diseases
Pedro Berraondo et al.
GUT (2019)
A New Era for Rare Genetic Diseases: Messenger RNA Therapy
Paolo G. Martini et al.
HUMAN GENE THERAPY (2019)
Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex
Yudong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers
Bianca Seminotti et al.
HUMAN MOLECULAR GENETICS (2019)
Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates
Xuling Zhu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca2+ homeostasis in the heart
Cristiane Cecatto et al.
FEBS JOURNAL (2018)
A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
Staci Sabnis et al.
MOLECULAR THERAPY (2018)
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Lei Jiang et al.
NATURE MEDICINE (2018)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
Ding An et al.
CELL REPORTS (2017)
Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies
Moacir Wajner et al.
BIOSCIENCE REPORTS (2016)
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
Kevin J. Kauffman et al.
BIOMATERIALS (2016)
Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database
Loren D. M. Pena et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
Kevin J. Kauffman et al.
NANO LETTERS (2015)
Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients
Julien Baruteau et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development
Mariano Severgnini et al.
CYTOTECHNOLOGY (2012)
Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy
Allison M. Keeler et al.
MOLECULAR THERAPY (2012)
Identification and characterization of new long chain Acyl-CoA dehydrogenases
Miao He et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation Complexes
Yudong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models
Ute Spiekerkoetter et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening
Ute Spiekerkoetter
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Matthew D. Hirschey et al.
NATURE (2010)
Carnitine supplementation induces acylcarnitine production in tissues of very long-chain Acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine
Sonja Primassin et al.
PEDIATRIC RESEARCH (2008)
A new genetic disorder in mitochondrial fatty acid β-oxidation:: ACAD9 deficiency
M. He et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects - Implications for a mechanism linking obesity and type 2 diabetes
Jolita Ciapaite et al.
FEBS JOURNAL (2006)
Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase
VJ Exil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid β-oxidation
AM Schuler et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress
U Spiekerkoetter et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Very-long-chain acyl-coenzyme A dehydrogenase deficiency in mice
VJ Exil et al.
CIRCULATION RESEARCH (2003)
Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse
KB Cox et al.
HUMAN MOLECULAR GENETICS (2001)
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
MM Hoeper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
